檢驗科通知
檢字 員基10915
日 期:2020年5月18日
受文者:全體醫護人員
主 旨:異動生化與免疫檢驗項目檢驗方法、採檢需求及生物參考區間
說 明:
1. 自2020年5月20日09:00起,生化、血中藥物濃度與藥物濫用檢驗項目之檢測
儀器由Siemens Dimension RXL/EXL異動為Beckman Coulter AU分析儀;甲狀腺
項目,檢驗儀器由Siemens Immulite 2000XPi異動為Beckman Coulter DxC分析儀
。檢驗方法、檢體採集需求及生物參考區間同步異動。檢驗項目相關注意事項,
包含病人準備、採檢及傳送方式、報告完成時間及生物參考區間等,請參考本院
主網頁檢驗資訊查詢系統 (http://172.24.19.114:8080/LabSearch/)。
2. 生化檢驗項目檢驗前需求-病人準備及採檢容器異動摘要
(1) 血液檢體採檢試管:除試劑製造商規範無法使用綠頭管採檢項目外(Lithium,
γ-Glutamyltransferase(rGT)、Digoxin),採檢試管將異動為綠頭管以提升檢驗
報告時效及減少干擾。
(2) 以下檢驗項目建議病人空腹至少8小時抽血:
Glucose(AC)(飯前血糖)、Triglyceride、HDL、Fe
3. 生物參考區間異動說明
(1)生化檢驗項目生物參考區間未異動項目:Albumin(Body fluid)、Amylase (Body
fluid)、Urine Urea Nitrogen(Body fluid)、Carbamazepin(Serum)、Cholesterol Tota
(Serum)、Creatinine(Body fluid)、 Alcohol (Serum)、Glucose(Serum)、Glucose
(Body fluid)、HDL-Cholesterol(Serum)、Lactate Dehydrogenase(Body fluid)、
Lactate Dehydrogenase(CSF)、LDL-Cholesterol(Serum)、Lithium(Serum)、Lipase
(Body fluid)、Magnesium (Urine)、Phenytoin(Serum)、Triglyceride(Serum)、
Triglyceride(Body fluid)、Total Protein(Body fluid)、Urinary/CSF Protein (CSF)、
Valproic acid(Serum)
(3) 生化檢驗項目生物參考區間有異動項目如下:
檢驗項目
|
檢體別
|
單位
|
異動前
|
異動後
|
Albumin
|
Serum
|
g/dL
|
3.4-5.0
|
3.5 - 5.7
|
Alanine
Aminotransferase
|
Serum
|
U/L
|
9-42
|
11-40
|
Ammonia
|
Serum
|
ug/dL
|
19-54
|
31-123
|
Amylase
|
Serum
|
U/L
|
25-115
|
29-103
|
Amylase
|
Urine
|
U/L
|
59-401 U/day
|
M: 16-491
F: 21-447
|
Aspartate
Aminotransferase
|
Serum
|
U/L
|
15-37
|
15-41
|
Alkaline
Phosphatase
|
Serum
|
U/L
|
46-116
|
34-104
|
Urine
Urea Nitrogen
|
Serum
|
mg/dL
|
7-18
|
7-25
|
Urine
Urea Nitrogen
|
Urine
|
mg/dL
|
7-20 g/day
|
7-16 g/day
|
Benzodiazepin
|
Urine
|
ng/mL
|
<200
|
Negative
|
Calcium
|
Serum
|
mg/dL
|
8.5-10.1
|
8.6-10.3
|
Calcium
|
Urine
|
mg/dL
|
42.0-353.0 mg/day
|
100-300 mg/day
|
Creatine Kinase
|
Serum
|
U/L
|
M: 39-308
F: 26-192
|
30-223
|
Chloride
|
Serum
|
mmol/L
|
98-107
|
101-109
|
Creatinine
|
Serum
|
mg/dL
|
M: 0.7-1.3
F: 0.55-1.02
|
M: 0.7-1.3
F: 0.6-1.2
|
Creatinine
|
Urine
|
mg/dL
|
M:950-2490mg/day;
F:600-1800 mg/day
|
M:800~2000mg/day
F:600~1800 mg/day
|
C-Reactive
Protein
|
Serum
|
mg/dL
|
<0.3
|
<1.0
|
Direct Bilirubin
|
Serum
|
mg/dL
|
≦2.0
|
0.03-0.18
|
γ-Glutamyl
transferase
|
Serum
|
U/L
|
M: 15-85
F: 5-55
|
9-64
|
Glucose
|
CSF
|
mg/dL
|
Not available
|
Adult: 40-70
Child: 60-80
|
Iron
|
Serum
|
μg/dL
|
M: 65-175
F:50-170
|
50-212
|
Lactate
|
Plasma
|
mmol/L
|
0.4-2.0
|
0.5-2.2
|
Lactate
|
CSF
|
mmol/L
|
0.6-2.2
|
1.1-2.4
|
Lactate
Dehydrogenase
|
Serum
|
U/L
|
M: 85-227
F:81-234
|
140-271
|
Lipase
|
Serum
|
U/L
|
73-393
|
11-82
|
Magnesium
|
Serum
|
mg/dL
|
1.8-2.4
|
1.9-2.7
|
Potassium
|
Plasma
|
mmol/L
|
3.5-5.1
|
3.4-4.5
|
Potassium
|
Urine
|
mmol/L
|
25-120 mmol/day
|
25-125 mmol/day
|
Phosphorus
|
Serum
|
mg/dL
|
2.6-4.7
|
2.5-5.0
|
Phosphorus
|
Urine
|
mg/dL
|
400-1300mg/day
|
300-1300 mg/day
|
Sodium
|
Serum
|
mmol/L
|
136-145
|
136-146
|
Total Bilirubin
|
Serum
|
mg/dL
|
0.2~1.0 Neonatal bilirubin:Cutoff:15
|
0.3~1.0
Neonatal bilirubin:
Cutoff:15
|
Theophylline
|
Serum
|
ug/mL
|
10~20.μg/mL
|
5.0~20.0 μg/mL
|
Total Protein
|
Serum
|
g/dL
|
6.4-8.2
|
6.4-8.3
|
Unsaturated Iron Binding Capacity
|
Serum
|
μg/dL
|
Not available
|
155-355
|
Uric Acid
|
Serum
|
mg/dL
|
M: 3.5-7.2
F:2.6-6.0
|
M: 4.4-7.6
F: 2.3-6.6
|
Uric Acid
|
Urine
|
mg/dL
|
150-990 mg/day
|
M: 250-800 mg/day
F: 250-750 mg/day
|
Urinary/CSF
Protein
|
Urine
|
mg/dL
|
<149.1 mg/day
|
50-100 mg/day
|
Urine Albumin
|
Urine
|
mg/dL
|
(1) Microalbumin:<3.0 mg/Dl
(2) Urine Creatinine:Not applicable
(3) ACR:<30 μg/mg
|
(1)Normal:<30.0
ug/mg creatinine;
(2)Microalbuminuria:30~300 ug/mg creatinine; (3)Clinical albuminuria:>300 ug/mg creatinine。
|
CKMB
|
Serum
|
ng/mL
|
0-3.6
|
0.6-6.3
|
Digoxin
|
Serum
|
ng/mL
|
0.9-2.00
|
0.50~2.00
|
High Sensitivity
Troponin I
|
Serum
|
ng/L
|
<0.056(ng/mL)
|
M: <19.8
F: <11.6
|
Free T4
|
Serum
|
ng/dL
|
0.89-1.76
|
0.61-1.12
|
Total T3
|
Serum
|
ng/mL
|
0.84-1.72
|
0.87-1.78
|
Total T4
|
Serum
|
μg/dL
|
4.5-12.5
|
6.09-12.23
|
TSH
|
Serum
|
μIU/mL
|
0.4-4.0
|
0.380-5.330
|
4. 相關訊息可洽:1046檢驗諮詢專線、1045品管教研組
檢驗科主任醫檢師 陳裕娟